Search Results
66 items found for "Agonist"
- Structural Basis for the Recognition of GPRC5D by Talquetamab, a Bispecific Antibody for Multiple Myeloma
The structure offers insights for optimizing antibody design against GPRC5D for relapsed or refractory
- Characterization, expressional and evolutionary analysis of five fish-specific CCRs (CCR4La, CCR4Lc, CCR12a1, CCR12a2, and CCR12b) in largemouth bass (Micropterus salmoides)
significantly induced in spleen of largemouth bass, indicating their important roles in the immune response against
- Evolutionary diversity of CXCL16-CXCR6: Convergent substitutions and recurrent gene loss in sauropsids
CXCL16, and CXCR6 in chickens may have altered CD8 TRM cell abundance, with implications for immunity against
- Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Amongst 256 patients, 92 received CAR-T, 55 BsAb and 109 ADC.
- Content and Conduct Policy | Dr. GPCR Ecosystem
Finally, you irrevocably waive and cause to be waived against Ecosystem.DrGPCR.com and its users any But we don't support content that promotes or condones violence against individuals or groups based on
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
The platform revealed different mechanisms-of-action of our lead compound when benchmarked against other
- Affiliate Policy | Dr. GPCR Ecosystem
GPCR harmless from and against all claims relating to your site. 4. Modification Dr.
- Terms and Conditions | Dr. GPCR Ecosystem
arbitration clause, which will, with limited exception, require the Customer to submit claims it has against agrees that Ecosystem.DrGPCR.com shall not be held liable for any loss or claim that Customer may have against
- Ep 154 with Dr Badr Sokrat
Yamina highlighted the need to project a certain presence and balance one’s actions against others in
- Trademark Policy | Dr. GPCR Ecosystem
GPCR Brand Features and to take action against any use that does not conform to these terms and conditions